Literature DB >> 12485664

Iodine-124 labelled annexin-V as a potential radiotracer to study apoptosis using positron emission tomography.

Matthias Glaser1, David R Collingridge, Eric O Aboagye, Lisa Bouchier-Hayes, O Clyde Hutchinson, Seamus J Martin, Pat Price, Frank Brady, Sajinder K Luthra.   

Abstract

Annexin-V is a calcium-dependent protein that binds with high affinity to phosphaditylserine exposed during apoptosis. The aim of this study was to radiolabel annexin-V with iodine-124 for use as a potential probe of apoptosis by positron emission tomography. Annexin-V was radioiodinated directly using the cyclotron-produced positron emitter iodine-124 by the chloramine-T (CAT) method and indirectly by the pre-labelled reagent N-succinimidyl 3-[124I]iodobenzoate ([124I]m-SIB). Some reaction parameters of the CAT method such as reaction time and pH were optimised to give radiochemical yields of 22.3 +/- 2.6%(n = 3, gel-filtration). After incubation with [124I]m-SIB, radiolabelled annexin-V was obtained in 14% and 25% yield by FPLC and gel-filtration, respectively. The radiochemical purities from direct and indirect labelling were 97.7 +/- 1.0%(n = 3) and 96.7 +/- 2.1%(n = 3), respectively. The new radiotracers could be stored for up to four days without significant de-iodination. The biological activity of radiolabelled annexin-V was tested in control and camptothecin-treated (i.e. apoptotic) human leukaemic HL60 cells. A significantly higher (21%) binding in treated cells was observed with [125I]m-SIB-annexin-V. The binding of [125I]m-SIB labelled annexin-V to camptothecin treated cells was blocked (68%) by a 100-fold excess of unlabelled annexin-V. Crown Copyright 2002 Published by Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12485664     DOI: 10.1016/s0969-8043(02)00239-7

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  18 in total

Review 1.  Apoptosis-detecting radioligands: current state of the art and future perspectives.

Authors:  Christophe M M Lahorte; Jean-Luc Vanderheyden; Neil Steinmetz; Christophe Van de Wiele; Rudi A Dierckx; Guido Slegers
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-05-12       Impact factor: 9.236

Review 2.  Development of radiotracers for oncology--the interface with pharmacology.

Authors:  Rohini Sharma; Eric Aboagye
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

3.  Annexin A5-conjugated polymeric micelles for dual SPECT and optical detection of apoptosis.

Authors:  Rui Zhang; Wei Lu; Xiaoxia Wen; Miao Huang; Min Zhou; Dong Liang; Chun Li
Journal:  J Nucl Med       Date:  2011-05-13       Impact factor: 10.057

4.  A Comparison of [99mTc]Duramycin and [99mTc]Annexin V in SPECT/CT Imaging Atherosclerotic Plaques.

Authors:  Yan Hu; Guobing Liu; He Zhang; Yanli Li; Brian D Gray; Koon Y Pak; Hak Soo Choi; Dengfeng Cheng; Hongcheng Shi
Journal:  Mol Imaging Biol       Date:  2018-04       Impact factor: 3.488

5.  Longitudinal PET imaging of doxorubicin-induced cell death with 18F-Annexin V.

Authors:  Shuo Hu; Dale O Kiesewetter; Lei Zhu; Ning Guo; Haokao Gao; Gang Liu; Naoki Hida; Lixin Lang; Gang Niu; Xiaoyuan Chen
Journal:  Mol Imaging Biol       Date:  2012-12       Impact factor: 3.488

6.  PET imaging of apoptosis with (64)Cu-labeled streptavidin following pretargeting of phosphatidylserine with biotinylated annexin-V.

Authors:  Nicole Cauchon; Réjean Langlois; Jacques A Rousseau; Guillaume Tessier; Jules Cadorette; Roger Lecomte; Darel J Hunting; Roberto A Pavan; Stefan K Zeisler; Johan E van Lier
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-09-22       Impact factor: 9.236

7.  Annexin A5-functionalized nanoparticle for multimodal imaging of cell death.

Authors:  Rui Zhang; Miao Huang; Min Zhou; Xiaoxia Wen; Qian Huang; Chun Li
Journal:  Mol Imaging       Date:  2013-05       Impact factor: 4.488

8.  High-quality 124I-labelled monoclonal antibodies for use as PET scouting agents prior to 131I-radioimmunotherapy.

Authors:  Iris Verel; Gerard W M Visser; Maria J W D Vosjan; Ronald Finn; Ronald Boellaard; Guus A M S van Dongen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-31       Impact factor: 9.236

Review 9.  Positron emission tomography imaging of small animals in anticancer drug development.

Authors:  Eric O Aboagye
Journal:  Mol Imaging Biol       Date:  2005 Jan-Feb       Impact factor: 3.488

10.  (124)I-L19-SIP for immuno-PET imaging of tumour vasculature and guidance of (131)I-L19-SIP radioimmunotherapy.

Authors:  Bernard M Tijink; Lars R Perk; Marianne Budde; Marijke Stigter-van Walsum; Gerard W M Visser; Reina W Kloet; Ludger M Dinkelborg; C René Leemans; Dario Neri; Guus A M S van Dongen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03-04       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.